Shares of other companies:
April 24, 2024 Google’s Third Cookie Phaseout Delay Amid Regulatory Hurdles
April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
Tesla Is An AI Company That The Market Won’t Reward For Now
April 24, 2024
Amazon: The Margin Train Is Gaining Speed
April 24, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
BAX Stock News and Mentions of Baxter International Inc. Stocktwits
Updated: April 26, 2024 (09:55)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Baxter International Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Baxter International Inc. (BAX).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Baxter International stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Baxter International Inc. (BAX)
April 25, 2024 (21:25) / "Zacks Commentary" (by Zacks Equity Research)
ResMed ( RMD ) Q3 Earnings and Revenues Surpass Estimates
ResMed (RMD) delivered earnings and revenue surprises of 10.94% and 1.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Somewhat-Bullish
April 25, 2024 (19:33) / "Benzinga" (by Benzinga Insights)
Decoding Edwards Lifesciences's Options Activity: What's the Big Picture? - Edwards Lifesciences ( NYSE:EW )
Financial giants have made a conspicuous bullish move on Edwards Lifesciences. Our analysis of options history for Edwards Lifesciences EW revealed 11 unusual trades. Delving into the details, we found 54% of traders were bullish, while 45% showed bearish tendencies.
In Article Trend: Somewhat-Bullish
April 18, 2024 (20:32) / "Benzinga" (by Benzinga Insights)
Behind the Scenes of Edwards Lifesciences's Latest Options Trends - Edwards Lifesciences ( NYSE:EW )
Whales with a lot of money to spend have taken a noticeably bearish stance on Edwards Lifesciences. Looking at options history for Edwards Lifesciences EW we detected 8 trades. If we consider the specifics of each trade, it is accurate to state that 12% of the investors opened trades with ...
In Article Trend: Neutral
April 15, 2024 (07:12) / "PR Newswire"
Optical Biometry Devices Market size is set to grow by USD 93.26 million from 2023-2027, Rise in prevalence of ... - PR Newswire
Optical Biometry Devices Market size is set to grow by USD 93.26 million from 2023-2027, Rise in prevalence of ... PR ...
In Article Trend: Somewhat-Bullish
April 12, 2024 (15:00) / "Zacks Commentary" (by Zacks Equity Research)
Baxter's ( BAX ) New Injectables Aid Its Pharmaceutical Portfolio
Baxter (BAX) unveils its five injectable products, which strengthen its emphasis on unique products and expand the pharmaceutical portfolio of the business in important therapeutic areas.
In Article Trend: Somewhat-Bullish
April 12, 2024 (14:30) / "PR Newswire" (by MarketsandMarkets)
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
CHICAGO, April 12, 2024 /PRNewswire/ -- Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™.
In Article Trend: Somewhat-Bullish
April 12, 2024 (12:29) / "Zacks Commentary" (by Zacks Equity Research)
Comfort Systems USA and Boeing have been highlighted as Zacks Bull and Bear of the Day
Comfort Systems USA and Boeing are part of the Zacks Bull and Bear of the Day article.
In Article Trend: Somewhat-Bullish
April 11, 2024 (13:35) / "Zacks Commentary" (by Indrajit Bandyopadhyay)
3 Medical Device Stocks With Solid Dividend Yield: CAH & Others
Here we discuss three medical device stocks, Cardinal Health (CAH), Baxter International (BAX) and Fresenius Medical Care (FMS), with a solid five-year dividend growth history.
In Article Trend: Somewhat-Bullish
April 10, 2024 (15:58) / "Zacks Commentary" (by Zacks Equity Research)
Reasons to Hold Baxter International ( BAX ) in Your Portfolio
Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, raises optimism.
In Article Trend: Somewhat-Bullish
April 9, 2024 (18:45) / "PR Newswire"
Commercial Combi Ovens Market Size to Grow by USD 1225.74 million from 2023 to 2027, 46% of market growth is ... - PR Newswire
Commercial Combi Ovens Market Size to Grow by USD 1225.74 million from 2023 to 2027, 46% of market growth is ... PR ...
In Article Trend: Bullish
April 2, 2024 (16:08) / "Zacks Commentary" (by Zacks Equity Research)
Baxter's ( BAX ) Latest FDA Approval to Boost Infusion Therapy
Baxter's (BAX) Novum IQ Infusion Platform is likely to help enhance patient safety and efficiency for clinicians following the FDA's clearance.
In Article Trend: Somewhat-Bullish
April 1, 2024 (16:38) / "Benzinga" (by Vandana Singh)
Medical Devices Giant Baxter Secures FDA Approval For New Infusion Pump System - Baxter Intl ( NYSE:BAX )
Monday, the FDA granted 510 ( k ) clearance to Baxter International Inc's BAX Novum IQ large volume infusion pump ( LVP ) with Dose IQ Safety Software. Novum IQ LVP and Novum IQ syringe infusion pump ( SYR ) infusion pumps share a common user interface to associate a patient, medication, ...
In Article Trend: Somewhat-Bullish
April 1, 2024 (06:45) / "Associated Press" (by STAN CHOE)
Stock market today: Wall Street hangs near highs following the latest report to show a solid economy
Stock market today: Asian shares are mixed and Shanghai gains on strong China factory data The Associated Press ...
In Article Trend: Neutral
March 22, 2024 (20:15) / "Benzinga" (by Benzinga Insights)
Behind the Scenes of Edwards Lifesciences's Latest Options Trends - Edwards Lifesciences ( NYSE:EW )
Investors with a lot of money to spend have taken a bullish stance on Edwards Lifesciences EW. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
In Article Trend: Somewhat-Bullish
March 11, 2024 (08:00) / "Investors Business Daily" (by Investor's Business Daily)
Stocks With Rising Relative Strength: Baxter International
Baxter International ( BAX ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Monday, rising from 70 to 73. X This proprietary rating tracks technical performance by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in ...
In Article Trend: Bullish
March 6, 2024 (08:00) / "Investors Business Daily" (by Investor's Business Daily)
Stocks Showing Improved Relative Strength: Baxter International
Baxter International ( BAX ) had its Relative Strength ( RS ) Rating upgraded from 64 to 71 Wednesday - a welcome improvement, but still below the 80 or higher score you prefer to see. X This exclusive rating from Investor's Business Daily tracks price performance with a 1 ( worst ) to 99 ( ...
In Article Trend: Bullish
March 5, 2024 (20:21) / "Benzinga" (by Vandana Singh)
Why Are Dialysis Provider Stocks Trading Higher On Tuesday? - Fresenius Medical Care ( NYSE:FMS ) , DaVita ( NYSE:DVA )
Tuesday, Novo Nordisk A/S NVO released the headline results from the kidney outcomes trial, FLOW. The trial achieved its primary endpoint by demonstrating a statistically significant and superior reduction in kidney disease progression as well as cardiovascular and kidney death of 24% for people ...
In Article Trend: Neutral
February 29, 2024 (18:08) / "PR Newswire" (by Elanco Animal Health)
Elanco Animal Health is Executing on Plan to Deliver for Shareholders
Ancora Nominates Director Candidates Despite Elanco's Meaningful Operational Progress and Good Faith Engagement with the Investor
In Article Trend: Somewhat-Bullish
February 27, 2024 (01:02) / "Benzinga" (by Globe Newswire)
Oncology Nutrition Market Poised to Grow to USD 3.6 billion by 2031, With a 6.2% CAGR: Exclusive Report by Transparency Market Research, Inc.
Wilmington, Delaware, United States, Feb. 26, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global oncology nutrition market was projected to attain US$ 2.1 billion in 2022. It is anticipated to garner a 6.2% CAGR from 2023 to 2031 and by 2031, the market is likely to attain ...
In Article Trend: Neutral
February 26, 2024 (15:33) / "Benzinga" (by Globe Newswire)
Pediatric Medical Devices Market Set to Hit USD 47.4 billion by 2031, with 6.3% CAGR: Analysis by Transparency Market Research, Inc.
Wilmington, Delaware, United States, Feb. 26, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global pediatric medical devices market was projected to attain US$ 27.6 billion in 2022. It is anticipated to garner a 6.3% CAGR from 2023 to 2031 and by 2031, the market is likely to ...
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
Inovio Pharmaceuticals, Inc. (INO)
Kodiak Sciences Inc. (KOD)
Boston Scientific Corp. (BSX)
Clever Leaves Holdings Inc. (CLVR)
Allied Healthcare Products, Inc. (AHPI)
Medtronic plc. (MDT)
Aptorum Group Limited (APM)
Berkeley Lights, Inc. (BLI)
Pasithea Therapeutics Corp. (KTTA)
Doximity, Inc. (DOCS)
This website uses cookies to ensure you get the best experience on our website